Difference between revisions of "Cashen A, et al. Biol. Blood Marrow Transplant. (2008) cited as Ref 629 in DOI: 10.1038/s41392-020-0110-5 (Q9892)"
Jump to navigation
Jump to search
(Created claim: title (P93): A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 1253-1261, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 1253-1261 | ||
| Property / Page(s): 1253-1261 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:47, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Cashen A, et al. Biol. Blood Marrow Transplant. (2008) cited as Ref 629 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Cashen A
0 references
2008
0 references
Biol. Blood Marrow Transplant.
0 references
14
0 references
A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma (English)
0 references
1253-1261
0 references
